Sponsor Pipeline

COMPASS Pathways Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
0
Recruiting
2
Phase 3
2
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-11 NCT05711940
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With…		 date change Primary completion moved earlier: 2026-02 -> 2025-11-13
2026-08-11 NCT05624268
Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD		 Trial completed
Active Trials by Phase
Phase 3
1
Phase 2/3
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05711940 Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With… Treatment Resistant Depression Active, Not Recruiting
Phase 2/3
NCT07570654 Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in… PTSD - Post Traumatic Stress Disorder Not Yet Recruiting
Phase 2
NCT05733546 A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the… Major Depressive Disorder Active, Not Recruiting
Disease Areas
Depression (2) PTSD (1)
Get alerts when COMPASS Pathways's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free